Indivior Pharmaceuticals, Inc. INDV
$38.34
▲ +0.92% 24H
About
Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on treating substance use disorders and related mental health conditions. The company concentrates on evidence-based therapies for opioid use disorder, including long-acting injectable and sublingual formulations designed to support adherence …
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees827
TickerINDV
Statistics
Market Cap$4.68B
Revenue (TTM)$1.24B
Net Income$210.0M
Net Margin16.9%
EPS$1.64
P/E19.53
P/S3.49
P/B-33.22
EV/EBITDA10.48
ROE-212.1%
Dividend Yield—
Price$38.34
Data: Twelve Data · Revenue = mcap / P/S